These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 8859258)
21. Hyperprostaglandin E syndrome: use of indomethacin and steroid, and death due to necrotizing enterocolitis and sepsis. Cetinkaya M; Köksal N; Ozkan H; Dönmez O; Sağlam H; Kiriştioğlu I Turk J Pediatr; 2008; 50(4):386-90. PubMed ID: 19014056 [TBL] [Abstract][Full Text] [Related]
22. Studies on the renal receptors of loop diuretics. Greven J Clin Exp Hypertens A; 1983; 5(2):193-208. PubMed ID: 6831745 [TBL] [Abstract][Full Text] [Related]
23. [Pharmacologic action of diuretics in the kidney]. Ferrari P; Frey FJ Ther Umsch; 2000 Jun; 57(6):345-50. PubMed ID: 10894017 [TBL] [Abstract][Full Text] [Related]
24. Role of prostaglandins in hyperprostaglandin E syndrome and in selected renal tubular disorders. Seyberth HW; Königer SJ; Rascher W; Kühl PG; Schweer H Pediatr Nephrol; 1987 Jul; 1(3):491-7. PubMed ID: 3153322 [TBL] [Abstract][Full Text] [Related]
25. A novel homozygous CLCNKB variant: An early presentation of classic Bartter syndrome in a neonate. Yaprak D; Kara H; Calisici E; Karagöl BS; Altan M Birth Defects Res; 2023 Oct; 115(17):1674-1679. PubMed ID: 37587715 [TBL] [Abstract][Full Text] [Related]
27. Reverse pharmacological effect of loop diuretics and altered rBSC1 expression in rats with lithium nephropathy. Michimata M; Fujita S; Araki T; Mizukami K; Kazama I; Muramatsu Y; Suzuki M; Kimura T; Sasaki S; Imai Y; Matsubara M Kidney Int; 2003 Jan; 63(1):165-71. PubMed ID: 12472779 [TBL] [Abstract][Full Text] [Related]
28. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function. De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961 [TBL] [Abstract][Full Text] [Related]
29. Studies on the pathogenesis of Bartter's syndrome. Baehler RW; Work J; Kotchen TA; McMorrow G; Guthrie G Am J Med; 1980 Dec; 69(6):933-8. PubMed ID: 7446558 [TBL] [Abstract][Full Text] [Related]
30. Variant of Bartter's syndrome with a distal tubular rather than loop of Henle defect. Puschett JB; Greenberg A; Mitro R; Piraino B; Wallia R Nephron; 1988; 50(3):205-11. PubMed ID: 3067102 [TBL] [Abstract][Full Text] [Related]
31. Role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome. Reinalter SC; Jeck N; Brochhausen C; Watzer B; Nüsing RM; Seyberth HW; Kömhoff M Kidney Int; 2002 Jul; 62(1):253-60. PubMed ID: 12081585 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of thick ascending limb Na+-K+-ATPase activity in salt-loaded rats by furosemide. Wald H; Scherzer P; Popovtzer MM Am J Physiol; 1989 Apr; 256(4 Pt 2):F549-55. PubMed ID: 2539744 [TBL] [Abstract][Full Text] [Related]
33. Type IV Bartter syndrome: report of two new cases. Zaffanello M; Taranta A; Palma A; Bettinelli A; Marseglia GL; Emma F Pediatr Nephrol; 2006 Jun; 21(6):766-70. PubMed ID: 16583241 [TBL] [Abstract][Full Text] [Related]
34. Effect of Etozolin on whole kidney function and fluid and electrolyte reabsorption in rat proximal convoluted tubules and loops of Henle. Greven J; Heidenreich O Arzneimittelforschung; 1977; 27(9a):1755-7. PubMed ID: 578764 [TBL] [Abstract][Full Text] [Related]
35. Furosemide-induced tubular dysfunction responding to prostaglandin synthesis inhibitor therapy in a child with nephrotic syndrome. Varma TH; Sharma A; Santhiya S; Dawman L; Tiewsoh K CEN Case Rep; 2018 Nov; 7(2):195-197. PubMed ID: 29568987 [TBL] [Abstract][Full Text] [Related]
37. Site and mechanism of action of diuretics. Kokko JP Am J Med; 1984 Nov; 77(5A):11-7. PubMed ID: 6496555 [TBL] [Abstract][Full Text] [Related]
38. [The neonatal form of Bartter's syndrome: current findings in etiology and physiopathology]. Proesmans WC Verh K Acad Geneeskd Belg; 1992; 54(3):253-93. PubMed ID: 1413986 [TBL] [Abstract][Full Text] [Related]
39. Renal hypoprostaglandism, hypertension, and type IV renal tubular acidosis reversed by furosemide. Sanjad SA; Keenan BS; Hill LL Ann Intern Med; 1983 Nov; 99(5):624-7. PubMed ID: 6579876 [TBL] [Abstract][Full Text] [Related]
40. [Pharmacologic bases of cardiovascular therapy with diuretics]. Reyes AJ Arch Inst Cardiol Mex; 1981; 51(3):291-303. PubMed ID: 7283541 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]